Tempus AI Shares Outstanding 1970-1969 | TEM
- Tempus AI shares outstanding for the quarter ending December 31, 1969 were 0M, a NAN% increase year-over-year.
- Tempus AI shares outstanding were 0B, a NAN% decline from .
- Tempus AI shares outstanding were 0B, a NAN% decline from .
- Tempus AI shares outstanding were 0B, a NAN% decline from .
Tempus AI Annual Shares Outstanding (Millions of Shares) |
---|
Tempus AI Quarterly Shares Outstanding (Millions of Shares) |
---|
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $5.082B | $0.000B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.979B | 19.75 |
Hims & Hers Health (HIMS) | United States | $4.300B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.021B | 0.00 |
Axonics (AXNX) | United States | $3.439B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.247B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $3.145B | 0.00 |
Azenta (AZTA) | United States | $2.808B | 157.88 |
Enovis (ENOV) | United States | $2.463B | 18.26 |
10x Genomics (TXG) | United States | $2.365B | 0.00 |
Privia Health (PRVA) | United States | $2.043B | 114.13 |
Schrodinger (SDGR) | United States | $1.414B | 0.00 |
Phreesia (PHR) | United States | $1.215B | 0.00 |
Omnicell (OMCL) | United States | $1.206B | 41.70 |
Standard BioTools (LAB) | United States | $0.656B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.645B | 0.00 |
Definitive Healthcare (DH) | United States | $0.625B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
Talkspace (TALK) | United States | $0.394B | 0.00 |
Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
Pulmonx (LUNG) | United States | $0.239B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.183B | 0.00 |
P3 Health Partners (PIII) | United States | $0.179B | 0.00 |
TruBridge (TBRG) | United States | $0.152B | 8.19 |
American Well (AMWL) | United States | $0.111B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
111 (YI) | China | $0.093B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.078B | 0.00 |
HeartBeam (BEAT) | United States | $0.066B | 0.00 |
MSP Recovery (LIFW) | United States | $0.066B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
Augmedix (AUGX) | United States | $0.042B | 0.00 |
Zepp Health (ZEPP) | China | $0.036B | 0.00 |
Akili (AKLI) | United States | $0.034B | 0.00 |
CareCloud (CCLD) | United States | $0.032B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.030B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Biotricity (BTCY) | United States | $0.009B | 0.00 |
Transgenomic (PRPO) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |